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BioaccumulationWastewater treatment plants (WWTPs) are oneof themain sources of pharmaceuticals and endocrine disrupting
compounds in freshwater ecosystems, and several studies have reported bioaccumulation of these compounds in
different organisms in those ecosystems. River bioﬁlms are exceptional indicators of pollution, but very few stud-
ies have focused on the accumulation of these emerging contaminants. The objectives of this study were ﬁrst to
develop an efﬁcient analytical methodology for the simultaneous analysis of 44 pharmaceuticals and 13 endo-
crine disrupting compounds in bioﬁlm, and second, to assess persistence, distribution, and bioaccumulation of
these contaminants in natural bioﬁlms inhabiting a WWTP-impacted river. The method is based on pressurized
liquid extraction, puriﬁcation by solid-phase extraction, and analysis by ultra performance liquid chromatogra-
phy coupled to a mass spectrometer (UPLC–MS/MS) in tandem. Recoveries for pharmaceuticals were 31–137%,
and for endocrine disruptors 32–93%. Method detection limits for endocrine disruptors were in the range of
0.2–2.4 ng g−1, and for pharmaceuticals, 0.07–6.7 ng g−1. A total of ﬁve endocrine disruptors and seven pharma-
ceuticals were detected in ﬁeld samples at concentrations up to 100 ng g−1.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hundreds of pharmaceuticals (PhACs) are ubiquitously detected in
freshwater ecosystems at concentrations ranging between ng L−1 to
μg L−1 (Daughton and Ternes, 1999). Despite these relatively low con-
centrations, PhACs may pose a risk to aquatic organisms because they
are designed to modify biochemical pathways in the human body at
low doses. Pharmaceuticals are developed to remain in the human
body for an adequate period of time to reach their therapeutic effect,
which means that a great majority of them are excreted mostly un-
changed and may persist in the environment (Boxall et al., 2004). An-
other group of emerging contaminants widely detected in freshwater
ecosystems are endocrine disrupting compounds (EDCs). Thesezaz).
. This is an open access article undercompounds belong to different chemical families, and are able to inter-
fere with the hormonal system of exposed organisms by mimicking or
counteracting natural hormones (Céspedes et al., 2005; Pojana et al.,
2007). The presence of these compounds in freshwater ecosystems is
of special concern considering that organisms are chronically exposed
to a mixture of PhACs and EDCs. Well-known examples of harmful ef-
fects due to exposure to emerging contaminants are the feminisation
of male ﬁsh (Kidd et al., 2007; Sumpter, 1998), inhibition of molting in
crustaceans (Rodriguez et al., 2007), and altered ﬁsh behavior
(Margiotta-Casaluci et al., 2014; Valenti et al., 2012).Wastewater treat-
ment plants (WWTP) have been identiﬁed as one of themain sources of
PhACs and EDCs for freshwater ecosystems (Daughton and Ternes,
1999; Fent et al., 2006; Petrovic et al., 2002). The threat posed by the re-
lease of those contaminants through WWTP efﬂuents is particularly
worrisome in streams or small rivers, where the dilution capacity of
the receiving freshwater ecosystem is small (Brooks et al., 2005).the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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attempts of regulation for some of these compounds in the European
Union (Collado et al., 2014), such as the anti-inﬂammatory diclofenac
or the synthetic hormones EE2, which have been included in the so
called ‘watch list’ of priority substances under theWater Framework Di-
rective for the “speciﬁc purpose of facilitating the determination of ap-
propriate measures to address the risk posed by these substances”
(European Commision, 2013). In the US, the Drinking Water Contami-
nant Candidate List also contains several PhACs and EDCs, including an-
tibiotics, and hormones (Environmental Protection Agency U.S., 2012).
Other PhACs, such as carbamazepine, sulfamethoxazole, diclofenac, ibu-
profen, naproxen, bezaﬁbrate, atenolol, erythromycin and gemﬁbrozil
have been classiﬁed as high priority pharmaceuticals to the water
cycle by the GWRC, Global Water Research Coalition (2008).
A comprehensive knowledge of the fate of these pollutants in all the
environmental compartments involved may be crucial to assessing the
potential risk associated with the discharge of WWTP efﬂuents. Previ-
ous studies have reported bioaccumulation of PhACs and EDCs in differ-
ent environmental compartments. For instance, some studies have
shown that sediments may be a sink of PhACs, due to the links withmi-
crobial degradation, in particular for those compounds not affected by
hydrolysis or photodegradation (Kunkel and Radke, 2008). Other stud-
ies have reported bioaccumulation of PhACs and EDCs in invertebrates
(Berlioz-Barbier et al., 2014; Huerta et al., 2015) and ﬁsh (Brooks
et al., 2005; Chu and Metcalfe, 2007; Du et al., 2012; Huerta et al.,
2013; Jakimska et al., 2013; Pojana et al., 2007; Ramirez et al., 2009).
The question that remains is whether river bioﬁlms could be a signiﬁ-
cant compartment for accumulation and transformation of these
emerging contaminants.
River bioﬁlms are communities composed mainly of bacteria, algae,
and fungi embedded in an organic polymer matrix. This matrix of
extracellular polymeric substances (EPS) is particularly relevant in the
sorption of compounds from the water phase, acting as a molecular
sieve, sequestering cations, anions, apolar compounds and particles
(Flemming and Wingender, 2010). Bioﬁlms are fundamental constitu-
ents of river ecosystems, as they are involved in vital functions such
nutrient retention (Bechtold et al., 2012). Their relatively rapid develop-
ment, widespread distribution and large biomass, together with their
capacity to absorb contaminants, suggest that bioﬁlms are exceptional
indicators of pollution (Sabater et al., 2007). Several studies have al-
ready shown that the presence of contaminants such as PhACs and
EDCs can affect the bioﬁlm negatively, altering its structure andmetab-
olism (Corcoll et al., 2014, 2015; Ricart et al., 2010; Rosi-Marshall et al.,
2013). Bioﬁlms have an important role in water puriﬁcation capacity
(Chenier et al., 2003; Tien and Chen, 2013). In fact, transport and fate
of contaminants in aquatic environments may be affected signiﬁcantly
by their sorption and remobilization interaction with bioﬁlms
(Headley et al., 1998), as they follow a transient development and col-
lapse, and in their detachmentmaymove even kilometers downstream
(Sabater et al., 2015), transporting contaminants within them. Thus,
bioﬁlms inﬂuence the transport and fate of emerging contaminants
such as PhACs and EDCs through biotic (bioaccumulation and biotrans-
formation by algae and bacteria) (Chenier et al., 2003; Tien and Chen,
2013) and abiotic (physical sorption to EPS) means (Headley et al.,
1998) . In this study, bioaccumulation refers to the concentration of tar-
get compounds foundwithin the bioﬁlm, both inside the cells and in the
matrix surrounding them, whichmay be led by active biological uptake
or passive physical sorption. Bioaccumulation in bioﬁlms has been re-
ported for a wide variety of contaminants, such as metals (Arini et al.,
2012;Morin et al., 2008; Serra and Guasch, 2009; Tien et al., 2013), pes-
ticides (Headley et al., 1998), hormones, surfactants and a psychiatric
drug (Correa-Reyes et al., 2007; Writer et al., 2011a, 2011b, 2013). Be-
cause of their acknowledged capacity to bioaccumulate different con-
taminants, they could also play a critical role in transferring PhACs
and other EDCs to higher trophic levels of riverine food webs within
freshwater ecosystems.However, information about bioaccumulation of PhACs and other
EDCs in river bioﬁlms is still non-existent for the great majority of
these compounds. To ﬁll the gaps in knowledge regarding the fate of
emerging contaminants in freshwater ecosystems, such as PhACs and
EDCs, it is essential to develop and validate appropriate analytical
methods. Therefore, the objectives of this study were ﬁrst to develop
an efﬁcient analytical methodology for the simultaneous analysis of
PhACs and EDCs in river bioﬁlm, and second, to assess persistence, dis-
tribution, and bioaccumulation of these trace contaminants in river
bioﬁlms affected by WWTP efﬂuents.
2. Materials and methods
2.1. Standards and solutions
A total of 44 PhACs and 13 EDCs were analyzed. A list of the target
analytes, molecular structures, and chemical properties are listed in
the supplementary material (Table S1). Individual stock standards and
labeled internal standards were prepared in methanol at a concentra-
tion of approximately 1000mg L−1. Stock solutions and 20mg L−1mix-
tures inmethanol were stored at−20 °C and diluted to 1mg L−1 before
each analytical run.
2.2. Sample collection and pre-treatment
The study was conducted in a section of the River Segre (Spain) af-
fected by the discharge of aWWTP efﬂuent. Water and bioﬁlm samples
were collected at ﬁve sites: one site upstream (500 m from theWWTP)
and four downstream of the local WWTP (from 500 to 4500 m). Water
samples (100 mL) were ﬁltered through 0.45 μm nylon membrane ﬁl-
ters and kept at−20 °C until analysis. Bioﬁlm was collected from sur-
faces of rocks that were removed from near-shore areas of the stream.
Bioﬁlm of at least one river cobble was gently scraped (volume =
40 mL) and used for each replicate. The bioﬁlm was placed directly
into Falcon® tubes and transported to the laboratory in a dark cool
box. Samples were lyophilised and kept frozen (−20 °C) until analysis.
2.3. Water extraction
Water was extracted according to the method developed by Gros
et al. (2012) for the analysis of PhACs, and also applied for the analysis
of EDCs. Brieﬂy, 3 mL of EDTA 1M (4%, v/v) were added to the samples.
SPE cartridges (Oasis HLB, 60mg)were conditionedwith 5mL ofmeth-
anol followed by 5 mL of ultra-pure water at a ﬂow rate of 2 mLmin−1.
Samples were loaded onto the cartridge at a ﬂow rate of 1 mL min−1.
Cartridges were rinsed with 6 mL of HPLC grade water, and were
dried in air for 30 min. Finally, analytes were eluted with 6 mL of
methanol and evaporated to dryness under a nitrogen stream and
reconstituted in 1 mL of methanol/water (10:90) for the analysis of
PhACs and methanol/water (50:50) for the analysis of EDCs. Finally,
5 μL of a 1 mg L−1 standard mixture containing labeled compounds
were added in the water extracts before analysis.
2.4. Bioﬁlm extraction and clean-up
Initially, sonication was pre-selected as the possible extraction
method, together with pressurized liquid extraction (PLE). Four sol-
vents were tested, including methanol, methanol/water (1:1), metha-
nol with 0.1% EDTA, and citric buffer (pH4)/acetonitrile (1:1, v/v), all
based on the authors' previous experience with pharmaceutical and
EDC extraction. To reduce the number of experiments and solvent con-
sumption, the results of one of these solvents were compared in both
extraction methods to ﬁnd which one had the best extraction recover-
ies. For sonication extraction, 200mg of freeze-dried bioﬁlmwas placed
in a 14-mL Falcon tubewith 10mL of the corresponding solvent. Extrac-
tion entailed 3 cycles of 10 min, and the supernatant was collected in a
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(PLE) was performed with ASE®350 (Thermo Scientiﬁc). Bioﬁlm
(200 mg) was placed in 10 mL cells together with diatomaceous earth
to ﬁll up the rest of the cell. Samples were extracted with the corre-
sponding solvent during 3 cycles of 5 min at 60 °C.
Extracts obtained using either PLE or sonication, were placed
under an N2 current until the organic solvent was evaporated till
dryness or, in the case of extracts containing an aqueous phase, till
5 mL volume. Evaporated extracts were then diluted to 100 mL of
H2O (organic solvent content b 0.05%). Further puriﬁcation of the ex-
tracts was performed by solid phase extraction (SPE) using the pro-
tocol for extraction of water samples described in the previous
section (Gros et al., 2012). Puriﬁed extracts were then evaporated
to dryness under a nitrogen stream and reconstituted in 1 mL of meth-
anol. Two aliquots (250 μl each) were evaporated and reconstituted in
the same volume of: a) methanol/water (10:90) for the analysis of
PhACs; and b) methanol/water (50:50) for the analysis of EDCs. Finally,
5 μL of a 1 mg L−1 standard mixture containing labeled compounds
were added to the bioﬁlm extracts as internal standard right before
the analysis.
2.5. Instrumental analysis
For the analysis of PhACs, extracts were analyzed using the meth-
od developed by Gros et al. (2012) using an ultra-performance liquid
chromatography (UPLC) system (Waters Milford, USA) coupled to a
hybrid quadrupole linear ion trap mass spectrometer Qtrap 5500
(Applied Biosystems), equipped with an electrospray ionization
source (ESI). Brieﬂy, an Acquity HSS T3 with 10 mM formic acid/am-
monium formate (pH 3.2) and methanol as the mobile phase at a
ﬂow rate of 0.5 mL min−1was applied for the analysis of PhACs in
positive mode, whereas an Acquity BEH C18 with acetonitrile and
5 mM ammonium acetate/ammonia (pH = 8) as mobile phase at a
ﬂow rate of 0.6 mL min−1 was applied for the PhACs analyzed in
negative mode.
For the analysis of EDCs, extracts were analyzed using the LC–MS-
MSmethod developed by Jakimska et al. (2013) in the same instrumen-
tal set up, using the Acquity BEH C18 column for both positive and neg-
ative modes with methanol and water (pH 9) as mobile phase at a ﬂow
rate of 0.4 mL min−1.
In both cases, the acquisition of the compoundswas done in selected
reaction monitoring (SRM) mode with the monitoring of two transi-
tions. The most intense transition was used for quantiﬁcation purposes
when possible, whereas the second onewas used to conﬁrm the identi-
ty of the target compounds. Quantiﬁcation was performed with a
matrix-matched calibration curve together with the internal standard
approach by adding the corresponding labeled compounds at a concen-
tration of 10 ng L−1 before analysis.
2.6. Calculation of bioaccumulation factors (BAFs)
Distribution coefﬁcient logarithms (Log Dow) for all the compounds
detected in water and/or bioﬁlm were calculated at pH 7.4 and com-
pared with the ﬁeld-derived bioaccumulation factors (BAFs). BAFs
were calculated considering themeasuredwater andbioﬁlm concentra-
tions in this study according to the following equation:
BAF
L
g
 
¼ conc: biota ng
g
 
=conc: water
ng
L
 
: ð1Þ
3. Results
3.1. Bioﬁlm extraction and puriﬁcation
Comparison between sonication extraction efﬁciencies using four
solvents (methanol, methanol/water (1:1), methanol with 0.1% EDTA,and citric buffer (pH4)/acetonitrile) resulted in the selection of citric
buffer (pH4)/acetonitrile as the ﬁnal extraction solvent, since the
majority of the compounds had higher recoveries (Fig. 1). Mixture
methanol/water was discarded, as many of the target analytes were
not recovered. The remaining three solvents showed similar recovery
efﬁciencies between them. However, the mixture citric buffer (pH4)/
acetonitrile produced slightly higher recoveries for most of the com-
pounds, includingmost of the EDCs, as well as lower standard deviation
between replicates. After selecting citric buffer (pH4)/acetonitrile as an
optimal solvent, extraction efﬁciencies were compared between using
sonication and PLE as an extraction methodology (Fig. 1). Although re-
coveries were similar, better reproducibility with PLE indicated that
this extraction method was more robust. Therefore, the ﬁnal extraction
method with PLE involved a sample size of 200 mg, 3 cycles of 5 min,
with 100% of fresh solvent each cycle, 90 s purge with N2 at 60 °C.
Final recoveries of EDCs and PhACs after extraction and puriﬁcation
with SPE are shown in Tables 1 and 2.3.2. Method validation
Extraction recoveries, linearity, method detection and quantiﬁcation
limits, accuracy, repeatability and reproducibility as well as matrix ef-
fects were calculated for EDCs and PhACs (see Tables 1 and 2). To deter-
mine recoveries, bioﬁlm samples were spiked with a mixture of the
target analytes at three levels: 10, 100 and 500 ng g−1, selected accord-
ing to previous studies in other biological matrices. Concentrations
obtained after the procedure, calculated by matrix-matched curves
(prepared with unexposed bioﬁlm grown in the lab) and internal stan-
dard calibration, were compared with the initial spiking levels. Extrac-
tion recoveries for all compounds were higher than 50%, except for
bisphenol A, triclosan, ibuprofen and sulfamethoxazole, whichwere be-
tween 32 and 42%, possibly due to the fact that the conditions chosen
were not the best for these speciﬁc compounds, as often occurs in
multi-residue methodologies, where a compromise is reached for
analytes with very different characteristics.
Method detection limits (MDLs) and method quantiﬁcation limits
(MQLs) were calculated in samples spiked at 10 ng g−1 (n = 3) as the
minimum amount of analyte with a signal-to-noise ratio of 3 and 10,
respectively. MDLs for EDCs were in the range of 0.20–2.4 ng g−1, and
for PhACs, 0.07–6.7 ng g−1.
Accuracy of the instrumental method was calculated as the devia-
tion of the measured mean concentration from the real concentration,
expressed in percentage from two repeated injections of a spiked sam-
ple (25 ng g−1). The instrumental precision (intra-day and inter-day)
was calculated from ﬁve repeated injections on the same day and on
ﬁve consecutive days of a spiked sample (25 ng g−1). Values were less
than 17% and 20% for EDCs and PhACs, respectively.
Signal alterations during analysis by mass spectrometry detectors
with electrospray interfaces are particularly noticeable in the case of bi-
ological samples. To evaluate the degree of matrix effects during analy-
sis of bioﬁlm, peak areas of bioﬁlm extracts (spiked at 25 ng g−1) were
compared to those of the analytes in the solvent mixture at the same
concentration. For EDCs, 92% of the compounds suffered ion suppres-
sion and only one of them ion enhancement (see Fig S1). In the case
of PhACs, 59% suffered ion suppression, 18% ion enhancement and the
remaining 23% was within the 20% signal variation that is not consid-
ered as a matrix effect (see Fig S2). Due to the obvious effects of the
co-eluting interferences in ionization, matrix-matched calibration, to-
gether with the addition of labeled compounds, was selected as the
most suitable approach to compensate for matrix effects during analy-
sis, as in previous studies (Huerta et al., 2013; Jakimska et al., 2013).
Calibration curves prepared in extracts of bioﬁlm from pristine sam-
pling sites (where no analytes were detected) were generated using
linear regression analysis (R2 N 0.98) in the concentration range from
0.01 to 100 ng mL−1.
Fig. 1. Comparison of extraction efﬁciencies (%) for a) four different solvents by sonication and b) two extraction methods (PLE and sonication) using ACN/Citric buffer for selected
pharmaceuticals.
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3.3.1. Water concentrations of PhACs and EDCs
A total of 81 multiple-class human and veterinary PhACs and 19
EDCs and related compounds, as well as some transformation products,
were analyzed in water. Recovery percentages and method detection
limits in water samples for PhACs and EDCs are published elsewhere
(Gros et al., 2012; Huerta et al., 2015). No compounds were detected
in the ﬁrst sampling point, before theWWTP input, as shown in Table 3.Table 1
Mean percent recoveries (n = 3) of 13 EDCs at three spiking levels, and method detection and
% recoveries (±RSD) LOD
10 ng/g 100 ng/g 500 ng/g MDL
Parabens
Benzylparaben 49 (±16) 62 (±16) 62 (±11) 0.20
Ethylparaben 72 (±3.5) 84 (±13) 90 (±5.0) 0.83
Methylparaben 82 (±9.4) 83 (±9.2) 87 (±6.6) 0.27
Propylparaben 64 (±13) 69 (±5.9) 85 (±4.7) 0.19
Plasticizers
Bisphenol A 32 (±8.6) 32 (±8.5) 53 (±19) 0.71
Hormones
Estrone 53 (±11) 68 (±18) 72 (±11) 0.74
Estrone-3-sulfate 37 (±30) 62 (±2.7) 80 (±1.3) 0.35
Estriol 78 (±2.2) 87 (±2.7) 93 (±4.9) 2.09
17α-ethinylestradiol 59 (±14) 64 (±11) 70 (±12) 2.40
Progesterone 59 (±4.7) 52 (±5.9) 51 (±3.4) 1.69
Flame retardants
TBEP 57 (±11) 56 (±3.8) 65 (±17) 0.70
TCEP 70 (±7.8) 79 (±4.9) 75 (±4.1) 2.13
Antibacterial
Triclosan 40 (±6.8) 41 (±9.7) 46 (±6.2) 0.71A total of 15 compounds, 14 PhACs from six therapeutic families –
analgesics, psychiatric drugs, diuretics, lipid regulators, calcium channel
blockers and antibiotics – and one ﬂame retardant were detected in the
ﬁrst sampling site after the WWTP discharge. The highest concentra-
tions were detected for diuretic compounds, lipid regulators and
analgesics/anti-inﬂammatories, with total concentrations of these ther-
apeutic families between 240 and 361 ng L−1, maximum concentration
thatwasmeasured for hydrochlorothiazide, a diuretic usually present at
high concentrations in WWTP-impacted waters (Gros et al., 2012;quantiﬁcation limits (MDL, MQL) in bioﬁlm (ng/g, dry weight).
s Precision (% RSD)
(ng/g) MQL (ng/g) Intra-day Inter-day Accuracy (%)
0.67 16.4 16.0 8.8
2.77 5.1 3.3 12.3
0.89 9.3 6.4 9.9
0.64 5.2 4.9 10.7
2.35 14.7 12.4 1.6
2.46 10.7 9.5 9.7
1.18 1.4 15.0 2.8
6.97 2.4 2.4 8.8
7.99 14.1 11.3 10.7
5.62 8.9 6.2 −1.9
2.35 3.4 16.8 −4.8
7.11 3.5 1.8 −2.1
2.36 6.6 6.1 8.8
Table 2
Mean percent recoveries (n = 3) of 44 PhACs at three spiking levels, and method detection and quantiﬁcation limits (MDL, MQL) in bioﬁlm (ng/g, dry weight).
% recoveries (±RSD) LODs Precision (% RSD)
10 ng/g 100 ng/g 500 ng/g MDL (ng/g) MQL (ng/g) Intra-day Inter-day Accuracy (%)
Analgesics/anti-inﬂammatories
1-OH-IBU 83 (±2.8) 97 (±5.3) 105 (±2.0) 1.86 6.19 9.9 5.3 2.8
Ibuprofen 31 (±18) 42 (±6.2) 86 (±3.4) 1.96 6.53 12.8 19.4 13.5
Diclofenac 60 (±0.5) 69 (±19) 74 (±9.5) 1.39 4.63 6.3 2.7 11.0
Diclofenac-glucuronide 75 (±15) 100 (±4.4) 111 (±6.1) 1.63 5.43 5.6 13.3 7.3
Meloxicam 67 (±2.3) 63 (±10) 63 (±7.5) 0.38 1.26 2.3 7.5 3.3
Piroxicam 103 (±14) 109 (±16) 101 (±5.1) 0.39 1.31 5.1 16.7 4.5
Propyphenazone 70 (±5.2) 84 (±3.4) 87 (±2.9) 0.17 0.56 2.9 5.2 6.4
Antibiotics
Azythromycin 71 (±12) 102 (±14) 101 (±11) 0.15 0.50 2.6 13.2 1.8
Chloramphenicol 94 (±7.7) 94 (±25) 97 (±0.8) 0.78 2.59 6.9 5.3 5.4
Ciproﬂoxacin 33 (±17) 70 (±12) 56 (±9.1) 0.68 2.26 11.6 16.0 −14.9
Clarithromycin 55 (±9.0) 61 (±16) 64 (±7.8) 0.27 0.92 7.8 9.0 15.8
Erythromycin 63 (±16) 69 (±3.1) 77 (±9.1) 6.71 22.37 4.3 12.1 −3.2
Oﬂoxacin 65 (±0.3) 70 (±16) 80 (±8.4) 0.25 0.83 16.4 10.5 −2.1
Sulfamethoxazole 24 (±12) 38 (±13) 46 (±19) 0.48 1.59 11.9 14.3 0.1
Antihelmintics
Thiabendazole 57 (±2.9) 61 (±4.0) 75 (±11) 0.14 0.48 5.4 10.8 12.4
Antiplatelet agent
Clopidogrel 75 (±16) 74 (±3.2) 109 (±9.5) 0.45 1.50 3.2 9.5 8.2
Calcium channel blockers
Diltiazem 52 (±10) 105 (±0.7) 113 (±1.5) 0.07 0.24 1.5 10.1 16.8
Norverapamil 77 (±11) 115 (±19) 101 (±5.2) 0.07 0.25 5.6 11.2 12.0
Verapamil 76 (±11) 126 (±22) 108 (±9.0) 0.06 0.21 8.5 11.1 10.6
Diuretic
Furosemide 57 (±29) 58 (±3.5) 64 (±9.3) 3.54 11.81 3.5 9.3 15.9
Hydrochlorothiazide 39 (±6.2) 79 (±2.7) 83 (±13) 0.14 0.46 2.7 13.2 −2.7
Trazodone 65 (±14) 87 (±14) 87 (±12) 0.10 0.35 14.1 13.9 8.1
Histamine H1 and H2 receptor antagonists
Desloratadine 80 (±17) 106 (±6.6) 116 (±10) 0.20 0.68 10.1 6.0 4.9
Lipid regulators
Bezaﬁbrate 78 (±3.7) 90 (±0.8) 97 (±12) 0.12 0.38 0.8 11.9 6.5
Fluvastatin 62 (±9.0) 62 (±9.0) 71 (±10) 0.67 2.23 10.4 14.5 6.2
Gemﬁbrozil 56 (±1.5) 68 (±2.6) 69 (±13) 0.60 2.00 2.5 12.7 1.2
Loratadine 85 (±13) 90 (±11) 123 (±9.0) 0.18 0.62 2.1 15.0 9.4
Pravastatin 67 (±13) 74 (±7.8) 86 (±9.7) 1.21 4.03 13.1 13.1 −0.1
Psychiatric drugs
Acridone 69 (±7.6) 92 (±3.3) 88 (±9.8) 0.14 0.46 4.7 4.3 3.1
OH-CBZ 70 (±7.8) 101 (±3.6) 70 (±7.8) 0.17 0.57 3.6 7.8 2.3
Epoxy-CBZ 72 (±6.6) 102 (±6.5) 111 (±16) 0.16 0.55 6.5 6.6 −6.5
Carbamazepine 64 (±4.9) 107 (±4.6) 104 (±8.2) 0.23 0.78 4.1 5.0 7.4
Citalopram 99 (±26) 104 (±4.4) 119 (±23) 0.33 1.11 4.9 9.6 10.6
Diazepam 76 (±8.5) 103 (±7.8) 103 (±0.5) 0.70 2.33 4.9 0.5 1.1
Fluoxetine 63 (±15) 66 (±9.1) 88 (±12) 0.78 2.60 10.1 14.7 4.8
Lorazepam 97 (±7.3) 113 (±6.4) 125 (±5.8) 0.78 2.60 6.4 9.5 1.9
Paroxetine 61 (±11) 68.1 (±15) 71 (±9.5) 0.61 2.04 11.5 9.5 9.1
Sertraline 61 (±11) 69 (±12) 104 (±19) 1.72 5.74 11.1 11.9 −4.0
Venlafaxine 75 (±9.5) 116 (±7.1) 137 (±24) 0.10 0.34 7.1 9.5 11.8
Synthetic glucocorticoid
Dexamethasone 83 (±15) 78 (±7.3) 89 (±14) 1.18 3.92 7.3 15.7 −0.2
Tranquilizer
Azaperone 49 (±11) 62 (±9.6) 81 (±15) 0.36 1.19 9.6 16.7 −10.7
β-blocking agents
Metoprolol 55 (±12) 69 (±15) 77 (±4.1) 0.20 0.68 4.1 11.7 7.3
Metoprolol acid 59 (±10) 59 (±12) 87 (±9.0) 2.88 9.61 9.0 10.2 10.0
Propanolol 62 (±14) 61 (±9.8) 94 (±4.4) 0.27 0.90 9.7 19.4 3.5
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about 40% in less than 5 km downstream, although the number of com-
pounds detected only decreased 13%. The impact of theWWTP efﬂuent
as a source of these contaminants is clearly observed from the consis-
tent die-away in the lower concentrations observed from the WWTP
outfall to the last downstream site.3.3.2. Bioﬁlm concentrations of PhACs and EDCs
Seven PhACs (out of 44) and ﬁve EDC (out of 13) were detected in
bioﬁlm samples (see Table 3). Fig. 2 shows the levels of major families
detected both inwater and bioﬁlm in all sampling points. Themost con-
centrated pharmaceutical was the anti-inﬂammatory diclofenac, which
was measured at 100 ng g−1 immediately downstream of the WWTP
Table 3
Detected PhACs and EDCs in water and/or bioﬁlm in River Segre.
Water concentration (ng/L) Bioﬁlm concentration (ng/g)
Control I1 I2 I3 I4 Control I1 I2 I3 I4
Endocrine disruptor compounds
Parabens
Ethylparaben n.d. n.d. n.d. n.d. n.d. n.d. 21.3 20.3 6.90 n.d.
Methylparaben n.d. n.d. n.d. n.d. n.d. n.d. 212 176 9.00 n.d.
Propylparaben n.d. n.d. n.d. n.d. n.d. n.d. 8.70 n.d. n.d. n.d.
Flame retardants
TBEP n.d. 65.3 41.4 21.5 15.9 3.60 50.8 14.1 17.3 4.80
Antibacterial
Triclosan n.d. n.d. n.d. n.d. n.d. 18.0 56.5 76.5 75.0 32.9
Pharmaceutical compounds
Analgesics/anti-inﬂammatories
1-OH-IBU n.d. 68.7 64.8 46.0 26.0 n.d n.d n.d n.d n.d
Ibuprofen n.d. 193 187 115 70.8 n.d n.d n.d n.d n.d
Diclofenac n.d. 29.1 25.6 19.9 n.d n.d. 103 23.5 bLOQ bLOQ
Antibiotics
Clarithromycin n.d. 32.8 24.5 19.1 7.7 n.d n.d n.d n.d n.d
Sulfamethoxazole n.d. 18.0 19.6 23.2 9.0 n.d n.d n.d n.d n.d
Calcium channel blockers
Diltiazem n.d. n.d. n.d. n.d. n.d. nd 11.8 nd 11.8 4.7
Norverapamil n.d. n.d. n.d. n.d. n.d. nd 20.9 18.7 11.2 4.20
Verapamil n.d. n.d. n.d. n.d. n.d. nd 21.7 20.2 11.1 14.4
Diuretics
Furosemide n.d. 45.8 38.6 33.1 bMQL n.d n.d n.d n.d n.d
Hydrochlorothiazide n.d. 311 296 221 199.6 n.d n.d n.d n.d n.d
Lipid regulator
Bezaﬁbrate n.d. 7.20 6.40 4.50 3.4 n.d n.d n.d n.d n.d
Gemﬁbrozil n.d. 286 222 157 76.9 nd 10.3 nd 4.00 nd
Pravastatin n.d. 44.0 25.7 23.9 13.8 n.d n.d n.d n.d n.d
Psychiatric drugs
Carbamazepine n.d. 38.6 23.6 21.3 15.0 n.d n.d n.d n.d n.d
OH-CBZ n.d. n.d. n.d. n.d. n.d. n.d. n.d. bLOQ 1.8 nd
Citalopram n.d. 4.70 n.d. n.d. n.d. n.d n.d n.d n.d n.d
Venlafaxine n.d. 21.1 13.8 9.3 2.4 n.d. n.d. 43.7 6.50 n.d.
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ing invertebrates (Huerta et al., 2015) and ﬁsh tissues in Mediterranean
rivers (Huerta et al., 2013). Other compounds detected included the an-
tihypertensive drugs diltiazem and verapamil, the lipid regulator gemﬁ-
brozil, and the psychiatric drug venlafaxine. Verapamil has previously
been detected in invertebrates (Hydropsyche sp.) at concentrations
around 3 ng g−1 downstream of a WWTP (Grabicova et al., 2014).Fig. 2. Relative presence of the groups of contaminants detected in boVenlafaxine has also been detected in ﬁsh homogenates at 0.6 ng g−1
in a heavily polluted river (Huerta et al., 2013). This is the ﬁrst study
to report such compounds from natural river bioﬁlms.
Maximum concentration around 200 ng g−1 was detected for
paraben preservative methylparaben within 1 km downstream of the
WWTP. This compound has previously been detected in ﬁsh at concen-
trations up to 80 ng g−1 (Jakimska et al., 2013). Antibacterial triclosanth water and bioﬁlm along 5 km after the discharge of a WWTP.
247B. Huerta et al. / Science of the Total Environment 540 (2016) 241–249and the ﬂame retardant TBEP were detected in all sampling points,
including the site upstream of the WWTP, in concentrations be-
tween 3 and 76 ng g−1. Triclosan has been found to have negative
effects both in bacterial and algal communities within the bioﬁlm at
environmentally-relevant water concentrations (Ricart et al., 2010).
Several compounds detected in the bioﬁlmwere not corresponding-
ly found in water: ethylparaben, methylparaben, propylparaben, triclo-
san, norverapamil, verapamil and OH-CBZ. This may suggest that
bioﬁlm was able to uptake compounds present at very low concentra-
tions in water (bMDLs) and bioaccumulate them. Other ﬁeld studies in-
dicated that steroidal hormones and 4-nonylphenol were detected in
bioﬁlm samples even when they were not in water (Writer et al.,
2011a, 2011b).
Still, a number of compounds detected inwaterwere not detected in
the bioﬁlm, such as, citalopram, pravastatin, sulfamethoxazole, furose-
mide, carbamazepine, and bezaﬁbrate, found inwater at low concentra-
tions (b50 ng L−1), even in the sampling sites close to theWWTP. Other
compounds found at higher concentration in water, such as hydrochlo-
rothiazide (max. conc. 361 ng L−1) and ibuprofen (max. conc.
193 ng L−1), were not detected either in bioﬁlm.
It is important to highlight that collectedwater samples in this study
were discrete, while the bioﬁlmwas allowed to grow for a longer period
and therefore was exposed to varying concentrations of these contami-
nants. Therefore correlation between water and bioﬁlm concentration
should only be considered as possible tendency of PhAC bioaccumula-
tion. Nevertheless, the levels found for contaminants in river water in
the sampling campaign are in line with those previously found in the
same site in another period of the day (Acuña et al., 2015) and thus,
they can be considered representative of the type of pollution in the
area.
3.3.3. Calculation of BAFs
In Fig. 3, three groups were easily identiﬁed: i) the compounds de-
tected in water and retained in bioﬁlm (in yellow), with log Dow be-
tween 1 and 4; ii) the compounds detected only in water (in blue),
generally with log Dow b 1; and iii) the compounds detected only in
bioﬁlm (in green), with log Dow N 1.5. The only points out of theFig. 3.Correlation between log BAFs and logDow (at pH7.4) for the compounds detected inwat
bioﬁlm (green), were calculated using MDLs in water as water concentrations to avoid givingnorm correspond to clarithromycin (log Dow pH 7.4= 3), an easily de-
gradable antibiotic, so its absence in bioﬁlm could be due to degradation
and not to lack of sorption; and carbamazepine.
4. Discussion
The presence of PhACs and EDCs in surface waters, and therefore
in other environmental compartments, may be affected by several
processes, such as photolysis, hydrolysis, sorption and biodegrada-
tion (Boreen et al., 2003; Radjenović et al., 2009; Yamamoto et al.,
2009; Lau et al., 2005; Rosenfeldt and Linden, 2004). Understanding
partitioning behaviorof contaminants in the biological compart-
ment, and the role of biota in the removal of these bioactive com-
pounds from surface water is of critical importance to studying
their ecological impact.
Octanol-water partition coefﬁcient (Kow) has been successfully ap-
plied to predict sorption processes for non-ionisable compounds (Fisk
et al., 1998; Meylan et al., 1999). More recently, the use of Dow to pre-
dict hydrophobic partition of the neutral species at a speciﬁed pH for
ionisable compounds has been widely accepted (Fitzsimmons et al.,
2001). However, Dow cannot be used alone to completely explain the
trends observed in Fig. 3. For instance, among the compounds detected
in the bioﬁlm, neutral compounds were present, such as the EDCs, and
ionisable compounds, both in positive and negative ionization, as the
PhACs (see Table S5). Probablymechanisms other than hydrophobic in-
teractions play important roles in sorption of PhACs, such as electro-
chemical interactions affected by the presence of aromatic rings and
functional groups (Yamamoto et al., 2009). Bioﬁlm bacterial and algal
communities together with the EPSmatrix are considered to play a sub-
stantial role in the sorption of organic and inorganic molecules (Dobor
et al., 2012).
This EPS matrix contains apolar regions, groups with hydrogen-
bonding potential, anionic groups (in uronic acids and proteins) and
cationic groups (for example, in amino sugars), facilitating sites of inter-
action to the contaminants dissolved in the water (Flemming and
Wingender, 2010; Flemming, 1995; Headley et al., 1998). For instance,
most bioﬁlm reactors in WWTPs are typically negatively charged ander (in blue), bioﬁlm (in green), or both (in yellow). BAFs of the compounds detected only in
BAF values = 0.
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charged compounds, while the sorption of anionic organic mole-
cules is slowed down due to electrostatic repulsion between the
negatively-charged molecules and the negatively-charged bioﬁlm
(Carlson and Silverstein, 1998; Riml et al., 2013). It is therefore
possible that the combination of both ionic binding as well as or-
ganic carbon partition may explain the sorption capacity of these
contaminants to bioﬁlm, even when they present low log Dow
(Kwon and Armbrust, 2008).
In addition to sorption, compounds readily partitioned to the biolog-
ical compartmentmay undergo other processeswithin the bioﬁlm, such
as biodegradation. For instance, bioﬁlm biodegradation of diclofenac
under controlled conditions was reported after some days of exposure
(Paje et al., 2002). Biodegradation may occur, not only due to the pres-
ence of the bioﬁlm bacterial community in the EPS matrix, but other
components, such as algae and fungi, may also have the capacity to
transform some of these contaminants. For example, Della Greca et al.
studied the removal and biotransformation of synthetic hormone EE2
by the microalga Selenastrum capricornutum and found that EE2 was
transformed into 3 products (Della Greca et al., 2008). Elimination of
emerging contaminants by the white-rot fungus Trametes versicolor
has also been applied in different studies (Badia-Fabregat et al., 2014;
García-Galán et al., 2011; Llorens-blanch et al., 2015; Yang et al.,
2013). In fact, several studies have considered the role of natural bioﬁlm
in freshwater ecosystems' water puriﬁcation capacity (Acuña et al.,
2015; Gurr and Reinhard, 2006; Kunkel and Radke, 2011), and Writer
et al. showed that attenuation of some EDCs in freshwater ecosystems
appears to be a combination of both sorption and biodegradation
processes (Writer et al., 2011a, 2011b) by the stream bioﬁlm and
sediments.
Bioaccumulation of PhACs and EDCs presented in this study demon-
strates that bioﬁlms could be very useful tools inmonitoring, as they are
naturally available and integrate chronic exposure. However, more re-
search is needed to determine how bioaccumulation and biodegrada-
tion are related, i.e. whether bioaccumulation increases bioavailability
and therefore increases the chances of biodegradation by bacteria,
algae and the enzymes contained in the EPS matrix, and consequently
the compounds accumulated in the bioﬁlm are also degraded. Bio-
magniﬁcation potential along the trophic chain should not be forgotten,
as bioﬁlm could constitute a secondary exposure pathway for other or-
ganisms (invertebrates, ﬁsh) coexisting in an ecosystem. Therefore,
reliable analytical methods that include metabolites in their analysis
are a useful tool for the determination of how bioﬁlm interacts with
the contaminants. They would allow determining how the bioﬁlm is
actually transforming theparent compounds. The analyticalmethodology
developed here allows the measurement of up to 5 known metabolites
and transformation products in bioﬁlm, including 1-OH-ibuprofen,
epoxy-carbamazepine, OH-carbamazepine, norverapamil and diclofenac
glucuronide.5. Conclusions
This study developed a simple, rapid, sensitive and efﬁcient analytical
method for the determination of 44 PhACs and 13 EDCs in river bioﬁlm.
To the best of the authors' knowledge, this is the ﬁrst study determining
such a large number of target compounds in bioﬁlm. The ﬁnal multi-
residue procedure consisted of pressurized liquid extraction, followed
by puriﬁcation of extract with solid-phase extraction, and the analysis
was performed by UHPLC–MS/MS, which provided the necessary sensi-
tivity and selectivity for these contaminants. The method was applied to
assess the bioaccumulation of these contaminants in natural bioﬁlm
from aWWTP-impacted river. Seven PhACs – diclofenac, diltiazem, gem-
ﬁbrozil, verapamil, norverapamil, OH-CBZ, and venlafaxine – and ﬁve
EDCs – ethylparaben, methylparaben, propylparaben, TBEP and triclo-
san –were detected in concentrations up to100 ng g−1.Acknowledgments
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